Literature DB >> 25464924

The dual nature of interleukin-10 in pemphigus vulgaris.

Michael Jeffrey Cho1, Christoph T Ellebrecht1, Aimee S Payne2.   

Abstract

The immunomodulatory cytokine interleukin-10 (IL-10) plays beneficial but also potentially detrimental roles in inflammation, infection, and autoimmunity. Recent studies suggest a regulatory role for IL-10-expressing B cells in the autoimmune blistering disease pemphigus vulgaris. Here we review the studies on IL-10 in pemphigus vulgaris and discuss the potential pathophysiological significance of these findings in comparison to prior studies of IL-10 in other human conditions. A better understanding of the complex roles of IL-10 in immune regulation may improve our understanding of pemphigus pathogenesis and treatment.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Interleukin-10; Pemphigus

Mesh:

Substances:

Year:  2014        PMID: 25464924      PMCID: PMC4437817          DOI: 10.1016/j.cyto.2014.11.002

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  106 in total

Review 1.  Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease.

Authors:  Shankar Subramanian Iyer; Gehong Cheng
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

2.  Enrichment of total serum IgG4 in patients with pemphigus.

Authors:  T Funakoshi; L Lunardon; C T Ellebrecht; A R Nagler; C E O'Leary; A S Payne
Journal:  Br J Dermatol       Date:  2012-09-27       Impact factor: 9.302

3.  Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.

Authors:  Natacha Colliou; Damien Picard; Frédérique Caillot; Sébastien Calbo; Stéphanie Le Corre; Annick Lim; Brigitte Lemercier; Brigitte Le Mauff; Maud Maho-Vaillant; Serge Jacquot; Christophe Bedane; Philippe Bernard; Frédéric Caux; Catherine Prost; Emmanuel Delaporte; Marie-Sylvie Doutre; Brigitte Dreno; Nathalie Franck; Saskia Ingen-Housz-Oro; Olivier Chosidow; Christine Pauwels; Catherine Picard; Jean-Claude Roujeau; Michèle Sigal; Emmanuelle Tancrede-Bohin; Isabelle Templier; Rüdiger Eming; Michael Hertl; Michel D'Incan; Pascal Joly; Philippe Musette
Journal:  Sci Transl Med       Date:  2013-03-06       Impact factor: 17.956

Review 4.  Regulatory B cells in autoimmune diseases.

Authors:  Min Yang; Ke Rui; Shengjun Wang; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2013-01-07       Impact factor: 11.530

5.  Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo.

Authors:  Damian Maseda; Susan H Smith; David J DiLillo; Jacquelyn M Bryant; Kathleen M Candando; Casey T Weaver; Thomas F Tedder
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

6.  Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections.

Authors:  Gabriela Senti; Reto Crameri; Daniela Kuster; Pål Johansen; Julia M Martinez-Gomez; Nicole Graf; Martin Steiner; Ludwig A Hothorn; Hans Grönlund; Christine Tivig; Anna Zaleska; Ozge Soyer; Marianne van Hage; Cezmi A Akdis; Mübeccel Akdis; Horst Rose; Thomas M Kündig
Journal:  J Allergy Clin Immunol       Date:  2012-03-30       Impact factor: 10.793

7.  IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses.

Authors:  Willem van de Veen; Barbara Stanic; Görkem Yaman; Marcin Wawrzyniak; Stefan Söllner; Deniz G Akdis; Beate Rückert; Cezmi A Akdis; Mübeccel Akdis
Journal:  J Allergy Clin Immunol       Date:  2013-02-26       Impact factor: 10.793

8.  Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice.

Authors:  R K Sellon; S Tonkonogy; M Schultz; L A Dieleman; W Grenther; E Balish; D M Rennick; R B Sartor
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

9.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

10.  Role of interleukin 10 in specific immunotherapy.

Authors:  C A Akdis; T Blesken; M Akdis; B Wüthrich; K Blaser
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more
  12 in total

Review 1.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

2.  IL-10+ Innate-like B Cells Are Part of the Skin Immune System and Require α4β1 Integrin To Migrate between the Peritoneum and Inflamed Skin.

Authors:  Skye A Geherin; Daniela Gómez; Raisa A Glabman; Gordon Ruthel; Alf Hamann; Gudrun F Debes
Journal:  J Immunol       Date:  2016-02-05       Impact factor: 5.422

Review 3.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls.

Authors:  Pegah Shahbazian; Maryam Izad; Maryam Daneshpazhooh; Hossein Mortazavi; Zahra Salehi; Shirin Behruzifar; Soheil Tavakolpour; Arghavan Azizpour
Journal:  Dermatol Pract Concept       Date:  2021-04-12

5.  Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.

Authors:  Rodolfo Pessato Timoteo; Marcos Vinicius da Silva; Camila Botelho Miguel; Djalma Alexandre Alves Silva; Jonatas Da Silva Catarino; Virmondes Rodrigues Junior; Helioswilton Sales-Campos; Carlo Jose Freire Oliveira
Journal:  Mediators Inflamm       Date:  2017-02-22       Impact factor: 4.711

6.  Autoreactive IgG and IgA B Cells Evolve through Distinct Subclass Switch Pathways in the Autoimmune Disease Pemphigus Vulgaris.

Authors:  Christoph T Ellebrecht; Eric M Mukherjee; Qi Zheng; Eun Jung Choi; Shantan G Reddy; Xuming Mao; Aimee S Payne
Journal:  Cell Rep       Date:  2018-08-28       Impact factor: 9.423

Review 7.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

8.  Analysis of Serum Cytokine Profile in Pemphigus.

Authors:  Sang Hee Lee; Won Jin Hong; Soo-Chan Kim
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

9.  Targeting interleukin 4 receptor α: A new approach to the treatment of cutaneous autoimmune bullous diseases?

Authors:  Roberto Russo; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi
Journal:  Dermatol Ther       Date:  2020-01-02       Impact factor: 2.851

Review 10.  Interleukin 10 and interleukin 10 receptor in paediatric inflammatory bowel disease: from bench to bedside lesson.

Authors:  Paulina Krawiec; Agnieszka Pawłowska-Kamieniak; Elżbieta Pac-Kożuchowska
Journal:  J Inflamm (Lond)       Date:  2021-03-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.